Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

30-day, Single-arm Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic Properties of Oral Rivaroxaban in Young Children With Various Manifestations of Venous Thrombosis

NCT02309411 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02309411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02309411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
30-day, Single-arm Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic Properties of Oral Rivaroxaban in Young Children With Various Manifestations of Venous Thrombosis
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
January 15, 2015
Completion date
April 5, 2017
Enrollment
46 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism